|
Clavis Pharma ASA (OSE: CLAVIS) will present results from the Phase I part of its Phase I/II study with ELACYT, within haematological cancers, at the American Society of Clinical Oncology (ASCO) Annual Meeting 2008, to be held in Chicago on 30 May to 3 June. |
Comenteaza